《2022年中国癌症发病和死亡报告》解读

2025-02-01 中国实用外科杂志发表于上海

本文将以《2022年中国癌症发病和死亡报告》为基础，结合既往癌症负担报告和全球癌症负担数据，对我国癌症负担的特点及变化趋势进行分析和解读。

中文标题：

发布机构：

发布日期：

2025-02-01

简要介绍：

2024年2月，国家癌症中心发布了《2022年中国癌症发病和死亡报告》，这是基于最新全国肿瘤登记及随访监测数据进行的测算，并与国际肿瘤研究机构（IARC）同期发布的GLOBOCAN 2022的中国数据一致。论文发表于Journal of the National Cancer Center，报告了2022年我国癌症的发病、死亡及其趋势变化。

相关资料下载：

《2022年中国癌症发病和死亡报告》解读.pdf

评论区 (3)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=2256663, encodeId=13f822566630a, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14bf9669197, createdName=ms9000001307693895, createdTime=Tue Mar 18 23:30:01 CST 2025, time=2025-03-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2256615, encodeId=f6432256615b3, content=感谢分享，希望能得到更过的知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fe79588115, createdName=ms9000000285324242, createdTime=Tue Mar 18 18:40:49 CST 2025, time=2025-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2256269, encodeId=11fb225626951, content=感谢您的分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/dc7b735700e1458a81dbbd2418ed68be-WBVuUZqXzOAb.jpg, createdBy=c6d55463285, createdName=Dew·, createdTime=Sun Mar 16 00:13:57 CST 2025, time=2025-03-16, status=1, ipAttribution=)]
2025-03-18 ms9000001307693895 来自北京

感谢

34 0 举报
[GetPortalCommentsPageByObjectIdResponse(id=2256663, encodeId=13f822566630a, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14bf9669197, createdName=ms9000001307693895, createdTime=Tue Mar 18 23:30:01 CST 2025, time=2025-03-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2256615, encodeId=f6432256615b3, content=感谢分享，希望能得到更过的知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fe79588115, createdName=ms9000000285324242, createdTime=Tue Mar 18 18:40:49 CST 2025, time=2025-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2256269, encodeId=11fb225626951, content=感谢您的分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/dc7b735700e1458a81dbbd2418ed68be-WBVuUZqXzOAb.jpg, createdBy=c6d55463285, createdName=Dew·, createdTime=Sun Mar 16 00:13:57 CST 2025, time=2025-03-16, status=1, ipAttribution=)]
2025-03-18 ms9000000285324242

感谢分享，希望能得到更过的知识

33 0 举报
[GetPortalCommentsPageByObjectIdResponse(id=2256663, encodeId=13f822566630a, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14bf9669197, createdName=ms9000001307693895, createdTime=Tue Mar 18 23:30:01 CST 2025, time=2025-03-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2256615, encodeId=f6432256615b3, content=感谢分享，希望能得到更过的知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fe79588115, createdName=ms9000000285324242, createdTime=Tue Mar 18 18:40:49 CST 2025, time=2025-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2256269, encodeId=11fb225626951, content=感谢您的分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/dc7b735700e1458a81dbbd2418ed68be-WBVuUZqXzOAb.jpg, createdBy=c6d55463285, createdName=Dew·, createdTime=Sun Mar 16 00:13:57 CST 2025, time=2025-03-16, status=1, ipAttribution=)]
2025-03-16 Dew·

感谢您的分享

41 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肿瘤威廉亚洲博彩公司

《2022年中国癌症发病和死亡报告》解读

相关威廉亚洲博彩公司

拓展阅读

科室

工具

服务